Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs

por Koureta, Evgenia, Cholongitas, Evangelos
Publicado 2023

Acute Severe Hepatitis of Unknown Origin in Children Across the World: A 2022 Source of Concern

por Chrysavgis, Lampros, Cholongitas, Evangelos
Publicado 2022

The evolution in the prioritization for liver transplantation

por Cholongitas, Evangelos, Burroughs, Andrew K.
Publicado 2012

Sofosbuvir: a novel oral agent for chronic hepatitis C

por Cholongitas, Evangelos, Papatheodoridis, George V.
Publicado 2014

Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects

por Cholongitas, Evangelos, Burroughs, Andrew K.
Publicado 2012

Tuberculous peritonitis after treatment for chronic hepatitis C

por Cholongitas, Evangelos, Nakouti, Theodora, Akriviadis, Evangelos
Publicado 2014

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease

por Makri, Evangelia, Cholongitas, Evangelos, Tziomalos, Konstantinos
Publicado 2016

Pulmonary manifestations of chronic liver disease: a comprehensive review

por Soulaidopoulos, Stergios, Goulis, Ioannis, Cholongitas, Evangelos
Publicado 2020

Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?

por Neokosmidis, Georgios, Cholongitas, Evangelos, Tziomalos, Konstantinos
Publicado 2021

Pulmonary function testing in patients with liver cirrhosis (Review)

por Georgakopoulou, Vasiliki Epameinondas, Asimakopoulou, Stavroula, Cholongitas, Evangelos
Publicado 2023

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation

por Cholongitas, Evangelos, Pipili, Chrysoula, Papatheodoridis, George V
Publicado 2017

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview

por Tampaki, Maria, Papatheodoridis, George V., Cholongitas, Evangelos
Publicado 2023

Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link

por Chrysavgis, Lampros, Giannakodimos, Ilias, Diamantopoulou, Panagiota, Cholongitas, Evangelos
Publicado 2022

Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?

por Protopapas, Adonis A., Cholongitas, Evangelos, Chrysavgis, Lampros, Tziomalos, Konstantinos
Publicado 2021

An Unusual Presentation of Diffuse Large B-Cell Lymphoma

por Gkoufa, Aikaterini, Georgakopoulou, Vasiliki E, Lakiotaki, Eleftheria, Cholongitas, Evangelos
Publicado 2022

Review article: Update on current and emergent data on hepatopulmonary syndrome

por Soulaidopoulos, Stergios, Cholongitas, Evangelos, Giannakoulas, George, Vlachou, Maria, Goulis, Ioannis
Publicado 2018

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update

por Sofogianni, Areti, Filippidis, Athanasios, Chrysavgis, Lampros, Tziomalos, Konstantinos, Cholongitas, Evangelos
Publicado 2020

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management

por Chrysavgis, Lampros, Ztriva, Eleftheria, Protopapas, Adonis, Tziomalos, Konstantinos, Cholongitas, Evangelos
Publicado 2020

Considerations for management of patients with diabetes mellitus and acute COVID-19

por Mougakou, Efterpi, Kyziroglou, Maria, Tsankof, Alexandra, Cholongitas, Evangelos, Tziomalos, Konstantinos
Publicado 2022

Clinical impact of microbiome in patients with decompensated cirrhosis

por Oikonomou, Theodora, Papatheodoridis, George V, Samarkos, Michael, Goulis, Ioannis, Cholongitas, Evangelos
Publicado 2018